Cargando…
Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy
The pathogenesis of glaucoma is strongly associated with the occurrence of autoimmune-mediated loss of retinal ganglion cells (RGCs) and additionally, recent evidence shows that specific antibody-derived signature peptides are significantly differentially expressed in sera of primary-open angle glau...
Autores principales: | Schmelter, Carsten, Fomo, Kristian Nzogang, Perumal, Natarajan, Manicam, Caroline, Bell, Katharina, Pfeiffer, Norbert, Grus, Franz H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723090/ https://www.ncbi.nlm.nih.gov/pubmed/31443184 http://dx.doi.org/10.3390/jcm8081222 |
Ejemplares similares
-
Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A (ANP32A)
por: Schmelter, Carsten, et al.
Publicado: (2023) -
Regulation of the HTRA2 Protease Activity by an Inhibitory Antibody-Derived Peptide Ligand and the Influence on HTRA2-Specific Protein Interaction Networks in Retinal Tissues
por: Schmelter, Carsten, et al.
Publicado: (2021) -
Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1
por: Fomo, Kristian Nzogang, et al.
Publicado: (2022) -
Comparison of Two Solid-Phase Extraction (SPE) Methods for the Identification and Quantification of Porcine Retinal Protein Markers by LC-MS/MS
por: Schmelter, Carsten, et al.
Publicado: (2018) -
Autoantigens in the trabecular meshwork and glaucoma‐specific alterations in the natural autoantibody repertoire
por: Beutgen, Vanessa M, et al.
Publicado: (2020)